Anicetti Vincent R

CIK 00017333751 companyREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001733375

Recent Transactions

50 trades

Award
Coherus Oncology, Inc.$CHRS
Common Stock
2021-07-06+50,000→ 124,790 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-07-06+150,000→ 150,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2021-04-28+20,000→ 73,402 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-03-05$15.46/sh−6,337→ 53,402 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-03-05$15.46/sh−20,312→ 59,739 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-03-05$9.30/sh+20,312→ 80,051 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-03-05−20,312→ 4,688 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-02-17$2.50/sh+2,488→ 62,227 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-02-17$17.45/sh−2,488→ 59,739 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-02-17−2,488→ 0 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-19$17.94/sh−2,500→ 59,739 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-19−2,500→ 2,488 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-19$2.50/sh+2,500→ 62,239 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-11+62,500→ 62,500 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-11+31,250→ 59,739 total
Tax Payment
Coherus Oncology, Inc.$CHRS
Common Stock
2021-01-10$18.18/sh−4,080→ 28,489 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-17$17.51/sh−2,500→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-17−2,500→ 4,988 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-17$2.50/sh+2,500→ 35,069 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-07−5,791→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-07$12.37/sh+3,000→ 35,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-07$12.70/sh+5,791→ 41,360 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-07$18.42/sh−8,791→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-07−3,000→ 123,000 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-04$12.70/sh+16,709→ 81,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-04$16.75/sh+32,291→ 64,860 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-04$18.85/sh−49,000→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-04−32,291→ 17,709 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-04−16,709→ 5,791 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-03$17.17/sh+36,736→ 69,305 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-03−36,736→ 0 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-03$18.67/sh−49,756→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-12-03−13,020→ 49,480 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-12-03$17.73/sh+13,020→ 82,325 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-18$12.70/sh+4,283→ 36,852 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-11-18−4,283→ 22,500 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-18$18.00/sh−4,283→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-11-17−2,500→ 7,488 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-17$17.50/sh−2,500→ 48,556 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-17$17.68/sh−3,567→ 32,569 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-17$2.50/sh+2,500→ 51,056 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-11-17$17.68/sh−12,420→ 36,136 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-10-19−717→ 26,783 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock
2020-10-19$17.89/sh−3,217→ 48,556 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-10-19$2.50/sh+2,500→ 51,056 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-10-19−2,500→ 9,988 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-10-19$12.70/sh+717→ 51,773 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock
2020-09-17$2.50/sh+2,500→ 51,056 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-09-17−2,500→ 12,488 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-09-17−2,500→ 27,500 total

Companies

Coherus Oncology, Inc.
Chief, Quality & Compliance
$CHRS

Recent Filings

Address

COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065

View on SEC.gov